메뉴 건너뛰기




Volumn 34, Issue 3-4, 1999, Pages 325-333

S-phase induction by interleukin-6 followed by chemotherapy in patients with chronic lymphocytic leukemia and non-Hodgkin's lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; CD20 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; INTERLEUKIN 6; PREDNISONE; VINCRISTINE SULFATE;

EID: 0344994635     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199909050957     Document Type: Article
Times cited : (3)

References (31)
  • 1
    • 0003398233 scopus 로고
    • The cytokines and their receptors
    • Callard R. E. & Gearing A. J. H. Eds. Academic Press, London
    • Callard R. E. & Gearing A. J. H. (1994) The cytokines and their receptors. In The Cytokine FactsBook (Callard R. E. & Gearing A. J. H. Eds), pp. 31-97. Academic Press, London.
    • (1994) The Cytokine Factsbook , pp. 31-97
    • Callard, R.E.1    Gearing, A.J.H.2
  • 2
    • 0023851809 scopus 로고
    • The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells
    • Muraguchi A., Hirano T., Tang B., Matsuda T., Horii Y., Nakajima K. & Kishimoto T. (1988) The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J. Exp. Med. 167, 332.
    • (1988) J. Exp. Med. , vol.167 , pp. 332
    • Muraguchi, A.1    Hirano, T.2    Tang, B.3    Matsuda, T.4    Horii, Y.5    Nakajima, K.6    Kishimoto, T.7
  • 4
    • 0025223325 scopus 로고
    • Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease
    • Klein B., Zhang X. G., Jourdan M., Portier M. & Bataille R. (1990) Interleukin-6 is a major myeloma cell growth factor in vitro and in vivo especially in patients with terminal disease. Curr. Top. Microbiol. Immunol. 166, 23.
    • (1990) Curr. Top. Microbiol. Immunol. , vol.166 , pp. 23
    • Klein, B.1    Zhang, X.G.2    Jourdan, M.3    Portier, M.4    Bataille, R.5
  • 7
    • 0027528694 scopus 로고
    • Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta
    • Aderka D., Maor Y., Novick D., Engelmann H., Kahn Y., Levo Y., Wallach D. & Revel M. (1993) Interleukin-6 inhibits the proliferation of B-chronic lymphocytic leukemia cells that is induced by tumor necrosis factor-alpha or -beta. Blood. 81, 2076.
    • (1993) Blood , vol.81 , pp. 2076
    • Aderka, D.1    Maor, Y.2    Novick, D.3    Engelmann, H.4    Kahn, Y.5    Levo, Y.6    Wallach, D.7    Revel, M.8
  • 8
    • 0027241344 scopus 로고
    • Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells
    • Van-Kooten C., Rensink I., Aarden L. & van-Oers R. (1993) Effect of IL-4 and IL-6 on the proliferation and differentiation of B-chronic lymphocytic leukemia cells. Leukemia. 7, 618.
    • (1993) Leukemia , vol.7 , pp. 618
    • Van-Kooten, C.1    Rensink, I.2    Aarden, L.3    Van-Oers, R.4
  • 11
    • 0028118686 scopus 로고
    • Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience
    • Maksymiuk A. W., Bratvold J. S., Ezzat W., Tan L. K. & Skinnider L. F. (1994) Non-Hodgkin's lymphoma in Saskatchewan. A review of 10 years' experience. Cancer. 73, 711.
    • (1994) Cancer. , vol.73 , pp. 711
    • Maksymiuk, A.W.1    Bratvold, J.S.2    Ezzat, W.3    Tan, L.K.4    Skinnider, L.F.5
  • 13
    • 0027385604 scopus 로고
    • Treatment of chronic lymphocytic leukaemia
    • Rozman C. Ed. Baillière, London
    • Binet J. L. (1993) Treatment of chronic lymphocytic leukaemia. In Chronic lymphocytic leukemia and related disorders (Rozman C. Ed), pp. 867-878. Baillière, London.
    • (1993) Chronic Lymphocytic Leukemia and Related Disorders , pp. 867-878
    • Binet, J.L.1
  • 14
    • 0029566878 scopus 로고
    • Key issues in the treatment of chronic lymphocytic leukaemia (CLL)
    • Catovsky D. & Murphy R. L. (1995) Key issues in the treatment of chronic lymphocytic leukaemia (CLL) [see comments]. Eur. J. Cancer. 31A, 2146.
    • (1995) Eur. J. Cancer. , vol.31 A , pp. 2146
    • Catovsky, D.1    Murphy, R.L.2
  • 15
  • 16
    • 0026578023 scopus 로고
    • Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA
    • Carayon P. & Bord A. (1992) Identification of DNA-replicating lymphocyte subsets using a new method to label the bromo-deoxyuridine incorporated into the DNA. J. Immunol. Methods. 147, 225.
    • (1992) J. Immunol. Methods , vol.147 , pp. 225
    • Carayon, P.1    Bord, A.2
  • 17
    • 0027813114 scopus 로고
    • Development and application of a sensitive radioimmunoassay for human granulocytemacrophage colony-stimulating factor able to measure normal concentrations in blood
    • Mortensen B. T., Schifter S., Pedersen L. B., Jensen A. N., Hovgaard D. & Nissen N. I. (1993) Development and application of a sensitive radioimmunoassay for human granulocytemacrophage colony-stimulating factor able to measure normal concentrations in blood. Exp. Hematol. 21, 1366.
    • (1993) Exp. Hematol. , vol.21 , pp. 1366
    • Mortensen, B.T.1    Schifter, S.2    Pedersen, L.B.3    Jensen, A.N.4    Hovgaard, D.5    Nissen, N.I.6
  • 20
    • 0029114152 scopus 로고
    • Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation
    • Jewell A. P., Lydyard P. M., Worman C. P., Giles F. J. & Goldstone A. H. (1995) Growth Factors Can Protect B-Chronic Lymphocytic Leukaemia Cells Against Programmed Cell Death Without Stimulating Proliferation. Leuk. Lymphoma 18, 159.
    • (1995) Leuk. Lymphoma , vol.18 , pp. 159
    • Jewell, A.P.1    Lydyard, P.M.2    Worman, C.P.3    Giles, F.J.4    Goldstone, A.H.5
  • 23
    • 0029937459 scopus 로고    scopus 로고
    • Interleukin-6 inhibits apoptosis and tumour necrosis factor induced proliferation of B - Chronic lymphocytic leukaemia
    • Reittie J. E., Yong K. L., Panaytotidis P. & Hoffbrand A. V. (1996) Interleukin-6 Inhibits Apoptosis and Tumour Necrosis Factor Induced Proliferation of B - Chronic Lymphocytic Leukaemia. Leuk. Lymphoma. 22, 83.
    • (1996) Leuk. Lymphoma , vol.22 , pp. 83
    • Reittie, J.E.1    Yong, K.L.2    Panaytotidis, P.3    Hoffbrand, A.V.4
  • 26
    • 0029147155 scopus 로고
    • Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer
    • Veldhuis G. J., Willemse P. H., Sleijfer D. T., van-der-Graaf W. T., Groen H. J., Limburg P. C., Mulder N. H. & de-Vries E. G. (1995) Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J. Clin. Oncol. 13, 2585.
    • (1995) J. Clin. Oncol. , vol.13 , pp. 2585
    • Veldhuis, G.J.1    Willemse, P.H.2    Sleijfer, D.T.3    Van-Der-Graaf, W.T.4    Groen, H.J.5    Limburg, P.C.6    Mulder, N.H.7    De-Vries, E.G.8
  • 27
    • 0342599005 scopus 로고
    • Stimulation of thrombopoiesis by recombinant human interleukin-6 (IL6) Pre- and Post-chemotherapy in preiously untreated sarcoma patients with normal hematopoiesis
    • Demetri G. D., Bukowski R. M., Samueis B., Gordon M., Antman K., Mehca E. A., Samuel S., Campion M., Levitt D. & Isaacs. R. (1993) Stimulation of Thrombopoiesis by Recombinant Human Interleukin-6 (IL6) Pre- and Post-Chemotherapy in Preiously Untreated Sarcoma Patients with Normal Hematopoiesis. Blood 82 (suppl 1), 367a.
    • (1993) Blood , vol.82 , Issue.SUPPL. 1
    • Demetri, G.D.1    Bukowski, R.M.2    Samueis, B.3    Gordon, M.4    Antman, K.5    Mehca, E.A.6    Samuel, S.7    Campion, M.8    Levitt, D.9    Isaacs, R.10
  • 30
    • 0000079275 scopus 로고    scopus 로고
    • A multicenter phase II study of iodine-131 anti-B1 antibody (Bexxar) in patients with Chemotherapy-relapsed/refractory low-grade or transformed low-grade B cell non-Hodgkin's lymphoma
    • Kaminski M. S., Vose J., Saleh M., Lister T. A., Knox S., Crowther D., Zelenetz A. D., Colcher D. & Wahl R. (1997) A multicenter phase II study of iodine-131 anti-B1 antibody (Bexxar) in patients with Chemotherapy-relapsed/refractory low-grade or transformed low-grade B cell non-Hodgkin's lymphoma. Blood 90 (suppl1), #2268a.
    • (1997) Blood , vol.90 , Issue.SUPPL. 1
    • Kaminski, M.S.1    Vose, J.2    Saleh, M.3    Lister, T.A.4    Knox, S.5    Crowther, D.6    Zelenetz, A.D.7    Colcher, D.8    Wahl, R.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.